|
|
|
|
Chronic hepatitis can be hidden, lifelong infection
HEPATITIS B AND C are serious viral diseases that can lead to lifelong infection, cirrhosis, liver cancer, liver failure and death. They often produce chronic, hidden infections. An estimated 1.25 million Americans are infected with hepatitis B, and about 30% of them have no signs or symptoms. An estimated 2.7 million Americans have chronic hepatitis C, and about 80% of them have no signs or symptoms. Both diseases are transmitted through blood and other bodily fluids.
|
| |
More>>
|
|
|
|
|
|
ICAAC homes in on recurrent infections
New antimicrobials, the increased pathogenicity and emergence of hyper-toxin-producing strains of Clostridium difficile, and new ways to treat recurrent genital herpes were some of the issues addressed at the recent 45th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), held recently in Washington, D.C.
|
| |
More>>
|
|
|
|
|
|
New biologic helps those with PI help themselves
Until now, patients with primary immunodeficiency (PI) were treated with intravenous immunoglobulin (IVIg) infusions, which were inconvenient and associated with serious adverse side effects, such as migraine headaches.
|
| |
More>>
|
|
|
|
|
|
Influence of a UTI empiric treatment pathway on physician prescribing in an academic medical center
In an attempt to improve patient outcomes and control costs, a guide to empiric antimicrobial therapy, including a urinary tract infection (UTI) algorithm, was distributed to hospital physicians at an academic medical center. A retrospective study was conducted to assess the impact of the guide on physician prescribing of empiric antimicrobial therapy for UTIs.
|
| |
More>>
|
|
|
